235 related articles for article (PubMed ID: 15255802)
1. Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity.
Ernstgård L; Warholm M; Johanson G
Br J Clin Pharmacol; 2004 Aug; 58(2):190-200. PubMed ID: 15255802
[TBL] [Abstract][Full Text] [Related]
2. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping of cytochrome P450 2E1 in vitro and in vivo.
Ernstgård L; Johanson G; Karlsson AS; Warholm M
Curr Drug Metab; 2007 Jun; 8(5):493-8. PubMed ID: 17584020
[TBL] [Abstract][Full Text] [Related]
4. The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone.
Loizou GD; Cocker J
Hum Exp Toxicol; 2001 Jul; 20(7):321-7. PubMed ID: 11530830
[TBL] [Abstract][Full Text] [Related]
5. Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.
Frye RF; Adedoyin A; Mauro K; Matzke GR; Branch RA
J Clin Pharmacol; 1998 Jan; 38(1):82-9. PubMed ID: 9597564
[TBL] [Abstract][Full Text] [Related]
6. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
[TBL] [Abstract][Full Text] [Related]
7. Effect of piperine on CYP2E1 enzyme activity of chlorzoxazone in healthy volunteers.
Bedada SK; Boga PK
Xenobiotica; 2017 Dec; 47(12):1035-1041. PubMed ID: 27670974
[TBL] [Abstract][Full Text] [Related]
8. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans.
Gebhardt AC; Lucas D; Ménez JF; Seitz HK
Hepatology; 1997 Oct; 26(4):957-61. PubMed ID: 9328319
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
[TBL] [Abstract][Full Text] [Related]
10. Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats.
Wan J; Ernstgård L; Song BJ; Shoaf SE
J Pharm Pharmacol; 2006 Jan; 58(1):51-61. PubMed ID: 16393464
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
[TBL] [Abstract][Full Text] [Related]
12. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
Chen L; Yang CS
Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
[TBL] [Abstract][Full Text] [Related]
13. In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
Doroshyenko O; Fuhr U; Kunz D; Frank D; Kinzig M; Jetter A; Reith Y; Lazar A; Taubert D; Kirchheiner J; Baum M; Eisenbrand G; Berger FI; Bertow D; Berkessel A; Sörgel F; Schömig E; Tomalik-Scharte D
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):433-43. PubMed ID: 19190172
[TBL] [Abstract][Full Text] [Related]
14. Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats.
Mizuno D; Tanaka E; Tanno K; Misawa S
Arch Toxicol; 2000 May; 74(3):139-44. PubMed ID: 10876999
[TBL] [Abstract][Full Text] [Related]
15. Chlorzoxazone: a probe drug the metabolism of which can be used to monitor one-point blood sampling in the carbon tetrachloride-intoxicated rat.
Tanaka E
Hum Exp Toxicol; 2001 Aug; 20(8):381-5. PubMed ID: 11727787
[TBL] [Abstract][Full Text] [Related]
16. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1.
Kharasch ED; Thummel KE; Mhyre J; Lillibridge JH
Clin Pharmacol Ther; 1993 Jun; 53(6):643-50. PubMed ID: 8513656
[TBL] [Abstract][Full Text] [Related]
17. [Changes of CYP2E1 activity in diabetic rat model].
Li L; Zhang Y
Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
[TBL] [Abstract][Full Text] [Related]
18. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats.
Shaik IH; Mehvar R
J Pharm Sci; 2011 Dec; 100(12):5281-92. PubMed ID: 21780121
[TBL] [Abstract][Full Text] [Related]
19. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.
Burckart GJ; Frye RF; Kelly P; Branch RA; Jain A; Fung JJ; Starzl TE; Venkataramanan R
Clin Pharmacol Ther; 1998 Mar; 63(3):296-302. PubMed ID: 9542473
[TBL] [Abstract][Full Text] [Related]
20. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism.
Benowitz NL; Peng M; Jacob P
Clin Pharmacol Ther; 2003 Nov; 74(5):468-74. PubMed ID: 14586387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
